Proud to finally have our paper on RARG agonists to prevent doxorubicin cardiotoxicity published in Cell Stem Cell. cell.com/cell-stem-cell…. We're hiring postdocs (NIH-funded) if you like to do more of this type of work! burridgelab.com Northwestern Feinberg School of Medicine

Postdoctoral Research Fellow Pluripotent Stem Cell Biology with Paul Burridge Northwestern University, Chicago, USA jobrxiv.org/job/northweste… #ScienceJobs

Very excited to have our paper on inhibiting SLC transporters with desipramine to prevent doxorubicin cardiotoxicity published in Circulation ahajournals.org/doi/abs/10.116… We're hiring postdocs (NIH-funded) if you like join us! burridgelab.com Northwestern Feinberg School of Medicine

In today's issue Circulation you can find ahajournals.org/doi/10.1161/CI…, an editorial Tim Kamp and I @UWSCRMC UW School of Medicine and Public Health wrote about a very interesting story on AIC and iPSC-CM by Paul Burridge lab. Original paper 👏ahajournals.org/doi/10.1161/CI…

ICYMI - Desipramine Attenuates Doxorubicin Cardiotoxicity - #AHAJournals Paul Burridge ahajournals.org/doi/10.1161/CI…

#Editorial: Preventing anthracycline-induced cardiotoxicity: functional genomics and iPSC-derived cardiomyocytes Valentina Lo Sardo ahajournals.org/doi/10.1161/CI…

#BCVS22 Scientific Sessions will be in person!! Pilar Alcaide, PhD @sumanthprabhu01 Dr. Nikki Purcell Jil Tardiff woldl Farah Sheikh Stefanie Dimmeler Hesham Sadek Gangjian Qin AHA Science @UC_CoMResearch

Julien Barc Inserm Inserm Grand Ouest @INSB_CNRS Nantes Université l'institut du thorax Rafik Tadros Charlotte Glinge Sean Jurgens Also thanks to EP colleagues from Foundation Leducq network on Na-channel Calum MacRae DasMachine-NU Paul Burridge Carol Ann Remme @MarioDelmar3. They studied MAPRE2 from chr18 locus and showed a new mechanism of Na-channel modulation via microtubule network in BrS risk Hartstichting

businesswire.com/news/home/2022…

So exciting! Paul Burridge was one of the first pioneers of open-access, low-cost, serum-free cell culture media formulations that not only bring us closer to economic viability for commercial #cultivatedmeat production but also reduce costs for researchers working in this space.

I am honored to be of the three recipients of #AVCIA which facilitates transition from postdoc to faculty.Thank you Additional Ventures and all my previous and current mentors Paul Burridge.

Thank you Lurie Cancer Center, Northwestern Feinberg School of Medicine. Together with the laboratories of Paul Burridge and Feng Yue, we are excited for this new beginning and honored to be among the first teams in the nation to undertake this ambitious and equally important task.

Thank you Chicago Inno for including us in your "23 Chicago Startups to Watch in 2023!" 🎉 "Clever Carnivore is looking to take the slaughter out of meat production. CC makes actual pork, beef & chicken using stem cell biology and bioengineering." 🧪🥩🧑‍🔬 bizjournals.com/chicago/inno/s…

Check out this job at Clever Carnivore: Principal Investigator/Senior Scientist linkedin.com/jobs/view/3540…

Awesome talk by Dr. Paul Burridge, using patient-specific hiPSC-derived cardiomyocytes to validate genes from GWAS for Doxorubicin-Induced Cardiotoxicity. #CardioResearch sciencedirect.com/science/articl… sciencedirect.com/science/articl…

Love having authors at #ISSCR2023 Booth #216! Read their paper in the StemCellReports 10th anniversary issue: cell.com/stem-cell-repo… Paul Burridge Davi Lyra-Leite 🎗️

lol wrong I ate it yesterday

🛠️ Building on prior work that established the suitable non-basal medium components for #hiPSC growth, Davi Lyra-Leite 🎗️ at the Paul Burridge lab & collaborators developed a simplified basal medium consisting of just 39 components. #OpenAccess in StemCellReports: bit.ly/3CwyaUX